← Back to headlines
Biotechnology Stocks Decline Despite Recent Cardiovascular Drug Advances
Shares in the biotech sector continued their downward trend even as researchers announced promising breakthroughs in treatments for heart conditions.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
58m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
1h ago